Analysis

Filter By :

Takshashila Discussion Document – Ethical Guidelines for Clinical Trials and Research in India

Download the Discussion Document in PDF This discussion document proposes a modified set of 8 ethical principles and a guidance questionnaire that researchers and ethics committees can refer to, to ensure that the research is within the ethical boundaries. ICMR’s ethical guidelines of 2017 need to be revised, with more...

Takshashila Discussion SlideDoc – A COVID-19 Vaccine Deployment Strategy for India

Download the Discussion SlideDoc in PDF by Shambhavi Naik, Ameya Paleja, Mihir Mahajan, Narayan Ramachandran, Sunila Dixit, Rahul Matthan, Nitin Pai and Pranay Kotasthane India should aim to vaccinate 80% of the population by 31st December 2021. There are 4 steps in vaccine deployment: estimate demand, secure vaccine supply, choose...

Takshashila Discussion Document- Analysing Digital Platforms’ Responses to COVID-19 Information Disorder

By Prateek Waghre and Rohan Seth Download the Discussion Document in PDF. Executive Summary This Discussion Document analyses the responses of digital platforms to the information disorders around COVID-19: During the pandemic, digital platforms may be able to exercise greater discretion in content moderation from increased calls for them to...

Takshashila Policy Advisory – A Policy Guide to Pooled Testing

By Shambhavi Naik Download the Policy Advisory in PDF Executive Summary: Pooled testing is a valuable tool in the routine surveillance of diseases. However, it is not a substitute for conventional diagnostic testing. The Indian Council of Medical Research (ICMR) advisory on pooled testing suggests using pooled testing approach in...

Recommended Draft Space Activities (Regulation) Bill, 2020

Download the recommended draft bill in PDF. Takshashila’s ‘The New Space Policy 2020‘ proposes a clear policy and regulatory structure that paves the way for growth of the nascent private space sector in India, thus contributing towards national development and advancing the frontiers of science and technology. The recommended Draft...

Takshashila Discussion SlideDoc: Increasing COVID-19 Testing Capacity in India

By Shambhavi Naik Executive Summary: The response to the COVID-19 pandemic rests on the ability to test for infected patients quickly and at scale. Exhaustive testing underpins effective containment strategies, helps estimate healthcare requirements and decreases the toll on delivery of essential services exerted by complete lockdowns. However, India’s current...

Takshashila Discussion Document: A Framework for Enabling Predictive Genomics to Improve Public Health in India

By Shambhavi Naik and Pavan Srinath Download the Discussion Document in PDF. Heritable genetic diseases, particularly rare diseases, contribute to a significant disease burden in India. In India’s urban areas, congenital malformations and genetic disorders are the third most common cause of mortality in newborns. Rare diseases by themselves are...

Takshashila Blue Paper: Governing Tech Platforms in India

The Takshashila Institution hosted a roundtable on 24 January 2020 to discuss policy solutions to some of the unique issues in platform marketplaces. Finding the balance between mitigating the harm caused by platforms while ensuring that these businesses continue to provide an enormous amount of social surplus is of paramount...

Takshashila Policy Proposal: The New Space Policy 2020

Download the proposal in PDF. Executive Summary The New Space Policy 2020 proposes a clear policy and regulatory structure that paves the way for growth of the nascent private space sector in India, thus contributing towards national development and advancing the frontiers of science and technology. Specifically, this paper recommends:...

Takshashila Policy Advisory – Comments on the National Guidelines for Gene Therapy Product Development and Clinical Trials

Download the Advisory in PDF This policy advisory contains recommendations and comments in response to the draft National Guidelines for Gene Therapy Product Development and Clinical Trials released by the Indian Council of Medical Research (ICMR) in consultation with the Department of Biotechnology (DBT) and Central Drug Standards Control Organisation...
1 2 3